* Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. DOI: 10.1056/NEJMoa2032183 Data derived from published Semaglutide clinical trials (STEP). Individual results vary. Medication
prescribed only after medical evaluation by a licensed provider.
All GLP-1 medications are available by prescription only and are prescribed solely at the discretion of a licensed medical professional following a comprehensive health review. Individual results may vary. Clarity Wellness Coaching does not diagnose, treat, or prescribe medication and is not a medical provider. Medication fulfillment and patient oversight are provided exclusively through licensed physicians and partnered U.S. compounding pharmacies.